Ana Toromanova

Ana Toromanova

Auto-generated profile, based on publicly available information

Ana Toromanova

Cochrane Austria, Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria (G.W., A.D., A.T., A.C., E.P., I.K.)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Annals of Internal Medicine
Verified
Journal Article
Open access
GGGerald Gartlehner
Gerald Gartlehner
ADAndreea Dobrescu
Andreea Dobrescu
ACAndrea Chapman
Andrea Chapman
ATAna Toromanova
Ana Toromanova
RERobert Emprechtinger
Robert Emprechtinger
GWGernot Wagner
Gernot Wagner
This systematic review and network meta-analysis summarizes studies on the effectiveness of different pharmacologic, nonpharmacologic, and alternative interventions for initial and second-line trea... Background: Primary care patients and clinicians may prefer alternative options to second-generation antidepressants for major depressive disorder (MDD). Purpose: To compare the benefits and harms ...

1 February 2023 in Annals of Internal Medicine
Verified
Journal Article
Open access
LALisa Affengruber
Lisa Affengruber
GWGernot Wagner
Gernot Wagner
ADAndreea Dobrescu
Andreea Dobrescu
ATAna Toromanova
Ana Toromanova
ACAndrea Chapman
Andrea Chapman
GGGerald Gartlehner
Gerald Gartlehner
This rapid review summarizes studies on patient values and preferences for initial or second-line treatment of major depression. Background: Developers of clinical practice guidelines need to take patient values and preferences into consideration when weighing benefits and harms of treatment options for depressive disorder. ...